IMLFF - InMed Pharmaceuticals Inc. (IMLFF) CEO Eric Adams on Q3 2019 Results - Earnings Call Transcript
InMed Pharmaceuticals, Inc. (IMLFF)
Q3 2019 Earnings Conference Call
May 15, 2019, 13:00 ET
Company Participants
Josh Blacher - Chief Business Officer
Eric Adams - President and CEO
Jeff Charpentier - CFO
Alexandra Mancini - SVP, Clinical and Regulatory Affairs
Conference Call Participants
Maxim Jacobs - Edison Group
Jerry Isaacson - Roth Capital
Presentation
Operator
Good morning my name is Sylvia and I will be your conference operator today. At this time I would like to welcome everyone to InMed's Third Quarter Fiscal 2019 Financial Results Business Update. [Operator Instructions].
I would like to turn